BeStock  

BioCryst Pharmaceuticals BCRX

US equityMarket cap rank #2720Drug Manufacturers - Specialty & Generic
$7.22 −$0.10 (-1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.10 -1.66%
Open$7.26
Prev close$7.32
Day range$7.15 – $7.39
Volume3.85M
Market cap$1.86B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership104.1%-0.56 pts vs. prior quarter
Institutions holding378-2 vs. prior quarter
Insider trades (recent)38 buys / 9 sellsNet buying
Short interest10.82% of floatDays to cover 5.1 · as of 30 Oct 2026
Short-sale volume share19.9%5-day average of daily volume

Short-sale volume as % of daily volume

10%15%20%25%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$5.19M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$5.5MSuper+$284.5KBig+$2.6MMid+$4.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 30.6% of shares outstanding.

Largest holders

  • BlackRock9.46%
  • RA Capital Management, L.P.6.15%
  • Deerfield Management Company, L.P.5.87%
  • State Street Global Advisors4.78%
  • Vanguard Capital Management, LLC4.38%
  • TCG Crossover Management, LLC4.28%
  • Vanguard Portfolio Management, LLC4.09%
  • Perceptive Advisors LLC4.01%

By investor type

  • Mutual Fund55.07%
  • Hedge Fund21.78%
  • VC/PE Fund17.08%
  • Public Company5.52%
  • Private Company2.31%
  • Government Pension Fund1.16%
  • Insurance Company0.93%
  • Individual/Insider0.89%

Reported short interest has fallen from 12.89% to 10.82% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Jupiter Fund Management Plc Mutual Fund 2026/Q3 +2,353,174 1.6%
JPMorgan Chase & Co. Public Company 2026/Q3 +1,517,083 0.6%
Morgan Stanley Public Company 2026/Q3 +1,450,617 1.3%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,450,617 1.3%
abrdn plc Mutual Fund 2026/Q3 +1,157,855 2.5%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +557,310 0.2%
Nan Fung Trinity (HK) Limited VC/PE Fund 2026/Q3 +488,200 0.4%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +581,109 0.9%
Millennium Management LLC Hedge Fund 2026/Q3 +3,207,008 1.3%
State Street Global Advisors Mutual Fund 2026/Q3 +2,982,738 5.9%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +2,874,855 4.0%
Jane Street Group, LLC Private Company 2026/Q3 +2,140,076 1.1%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +1,898,245 1.4%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +1,753,300 1.0%
AQR Capital Management Hedge Fund 2026/Q3 +1,746,572 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Aug 2026 Vincent Milano Independent Chairperson Other Acquisition +1,159 $9.70 94,348
30 Aug 2026 Steve Frank Independent Director Other Acquisition +1,288 $9.70 20,209
30 Aug 2026 Jill Milne Independent Director Other Acquisition +1,288 $9.70 5,660
30 Aug 2026 Jon Stonehouse Director Other Acquisition +644 $9.70 1,037,925
30 Aug 2026 Amy McKee Independent Director Other Acquisition +644 $9.70 32,527
10 Jun 2026 Vincent Milano Independent Chairperson Other Acquisition +15,294 – 27,794
10 Jun 2026 Vincent Milano Independent Chairperson Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 Alan Levin Independent Director Other Acquisition +15,294 – 27,794
10 Jun 2026 Alan Levin Independent Director Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 Steve Frank Independent Director Other Acquisition +15,294 – 29,038
10 Jun 2026 Steve Frank Independent Director Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 Jill Milne Independent Director Other Acquisition +15,294 – 27,566
10 Jun 2026 Jill Milne Independent Director Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 Theresa Heggie Independent Director Other Acquisition +15,294 – 27,794
10 Jun 2026 Theresa Heggie Independent Director Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 Jon Stonehouse Director Other Acquisition +15,294 – 382,494
10 Jun 2026 Jon Stonehouse Director Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 Steven K. Galson Independent Director Other Acquisition +15,294 – 27,794
10 Jun 2026 Steven K. Galson Independent Director Other Derivative Acquisition +33,540 $8.50 33,540
10 Jun 2026 A. Sanders Independent Director Other Acquisition +15,294 – 27,794

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 27,637,852 10.8% 5.1
15 Oct 2026 26,597,263 10.4% 5.8
30 Sep 2026 27,494,721 10.8% 4.6
15 Sep 2026 34,868,460 13.6% 7.3
31 Aug 2026 34,050,906 13.3% 14.4
14 Aug 2026 32,939,174 12.9% 8.0

Discussion

No comments yet — be the first to weigh in on BCRX.

Sign in to join the discussion.

Scroll to Top